Lavipharm
Born in Athens, Loukia “Vana” Lavidas holds a B.A. in Economics from Deree College in Athens and an MBA from La Verne University. She is fluent in English and French. After a long experience in charity foundations and especially after serving for seven years as Secretary General of ELPIDA (Friend’s Association of Children with Cancer), Mrs. Lavidas co-founded the Muscular Dystrophy Association (MDA Hellas), an Association for the care and welfare of those with neuromuscular disorders in Greece. Since its establishment in 2000, Ms. Lavidas serves as President of the Board. She is also a Trustee member of the American College (ACG) and board member of the Friends of National Art Gallery in Athens.
This person is not in the org chart
This person is not in any offices
Lavipharm
1 followers
Lavipharm SA is a Greek commercial and industrial enterprise engaged in the development, manufacture, marketing and distribution of pharmaceutical, cosmetic and over-the-counter (OTC) products. Its main pharmaceutical products cover such categories as anti-inflammatory, asthma controlling, neurological, antiseptic, analgesic, dermatological and gastrointestinal therapies. Its cosmetic products are offered under the brand names of Castalia Soins Dermocosmetiques and Laviderm Active Technology and are used for skin, face and body care, as well as for scalp and hair problems. Its OTC products include cold and flu remedies, oral care, dermatological products, condoms, antiseptics, analgesics, laxatives and gynecology products. It is the parent company of Lavipharm Group of Companies. In January 2014, Robertet SA acquired together with CODIF the HITEX company, specialized in subcontracting of carbon dioxide extraction, from Lavipharm SA.